Related references
Note: Only part of the references are listed.Phage Therapy of Mycobacterium Infections: Compassionate Use of Phages in 20 Patients With Drug-Resistant Mycobacterial Disease
Rebekah M. Dedrick et al.
CLINICAL INFECTIOUS DISEASES (2023)
The role of the animal host in the management of bacteriophage resistance during phage therapy
Baptiste Gaborieau et al.
CURRENT OPINION IN VIROLOGY (2023)
Phage therapy in pediatrics: the way forward for difficult-to-treat infections?
Annaleise R. Howard-Jones et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2022)
Combination of pre-adapted bacteriophage therapy and antibiotics for treatment of fracture-related infection due to pandrug-resistant Klebsiella pneumoniae
Anais Eskenazi et al.
NATURE COMMUNICATIONS (2022)
Mucus and mucus flake composition and abundance reflect inflammatory and infection status in cystic fibrosis
Matthew R. Markovetz et al.
JOURNAL OF CYSTIC FIBROSIS (2022)
Combination of in vivo phage therapy data with in silico model highlights key parameters for pneumonia treatment efficacy
Raphaelle Delattre et al.
CELL REPORTS (2022)
Ceftaroline versus vancomycin for treatment of acute pulmonary exacerbations of cystic fibrosis in adults
Marc D. Esquivel et al.
JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE (2022)
Mucin induces CRISPR-Cas defense in an opportunistic pathogen
Gabriel Magno de Freitas Almeida et al.
NATURE COMMUNICATIONS (2022)
Efficacy of phage therapy in preclinical models of bacterial infection: a systematic review and meta-analysis
Sergio Alejandro Gomez-Ochoa et al.
LANCET MICROBE (2022)
Variation in treatment preferences of pulmonary exacerbations among Australian and New Zealand cystic fibrosis physicians
Grace Currie et al.
BMJ OPEN RESPIRATORY RESEARCH (2021)
Synergistic activity of phage PEV20-ciprofloxacin combination powder formulation-A proof-of-principle study in a P. aeruginosa lung infection model
Yu Lin et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2021)
The pharmacokinetics of antibiotics in cystic fibrosis
Anne M. Akkerman-Nijland et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2021)
Bacteriophage therapy for infections in CF
Benjamin K. Chan et al.
PEDIATRIC PULMONOLOGY (2021)
Overcoming Challenges to Make Bacteriophage Therapy Standard Clinical Treatment Practice for Cystic Fibrosis
Renee N. Ng et al.
FRONTIERS IN MICROBIOLOGY (2021)
Targeting of Mammalian Glycans Enhances Phage Predation in the Gastrointestinal Tract
Sabrina Green et al.
MBIO (2021)
A Novel Group of Promiscuous Podophages Infecting Diverse Gammaproteobacteria from River Communities Exhibits Dynamic Intergenus Host Adaptation
Daniel Cazares et al.
MSYSTEMS (2021)
Cystic Fibrosis: Recent Insights into Inhaled Antibiotic Treatment and Future Perspectives
Giovanni Taccetti et al.
ANTIBIOTICS-BASEL (2021)
Bacteriophage cocktail and phage antibiotic synergism as promising alternatives to conventional antibiotics for the control of multi-drug-resistant uropathogenic Escherichia coli
Shikha Malik et al.
VIRUS RESEARCH (2021)
The Safety and Toxicity of Phage Therapy: A Review of Animal and Clinical Studies
Dan Liu et al.
VIRUSES-BASEL (2021)
Current and Emerging Therapies to Combat Cystic Fibrosis Lung Infections
Jim Manos
MICROORGANISMS (2021)
Phenotypic Characterization and Comparison of Cystic Fibrosis Rat Models Generated Using CRISPR/Cas9 Gene Editing
Alexandra McCarron et al.
AMERICAN JOURNAL OF PATHOLOGY (2020)
The arms race between bacteria and their phage foes
Hannah G. Hampton et al.
NATURE (2020)
Safety of bacteriophage therapy in severe Staphylococcus aureus infection
Aleksandra Petrovic Fabijan et al.
NATURE MICROBIOLOGY (2020)
Pleiotropy complicates a trade-off between phage resistance and antibiotic resistance
Alita R. Burmeister et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Abortive Infection: Bacterial Suicide as an Antiviral Immune Strategy
Anna Lopatina et al.
ANNUAL REVIEW OF VIROLOGY, VOL 7, 2020 (2020)
Achromobacter Infections and Treatment Options
Burcu Isler et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
Phage-Antibiotic Synergy Is Driven by a Unique Combination of Antibacterial Mechanism of Action and Stoichiometry
Carmen Gu Liu et al.
MBIO (2020)
Educating Patients on Unnecessary Antibiotics: Personalizing Potential Harm Aids Patient Understanding
Benjamin J. Miller et al.
JOURNAL OF THE AMERICAN BOARD OF FAMILY MEDICINE (2020)
A synthetic peptide sensitizes multi-drug resistantPseudomonas aeruginosato antibiotics for more than two hours and permeabilizes its envelope for twenty hours
Iosu Razquin-Olazaran et al.
JOURNAL OF BIOMEDICAL SCIENCE (2020)
Successful Treatment of Antibiotic-resistant, Poly-microbial Bone Infection With Bacteriophages and Antibiotics Combination
Ran Nir-Paz et al.
CLINICAL INFECTIOUS DISEASES (2019)
Mucus and Mucin Environments Reduce the Efficacy of Polymyxin and Fluoroquinolone Antibiotics against Pseudomonas aeruginosa
Tahoura Samad et al.
ACS BIOMATERIALS SCIENCE & ENGINEERING (2019)
Engineered bacteriophages for treatment of a patient with a disseminated drug-resistant Mycobacterium abscessus
Rebekah M. Dedrick et al.
NATURE MEDICINE (2019)
Mucus accumulation in the lungs precedes structural changes and infection in children with cystic fibrosis
Charles R. Esther et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Early clinical experience of bacteriophage therapy in 3 lung transplant recipients
Saima Aslam et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2019)
Bacteriophage Adherence to Mucus Mediates Preventive Protection against Pathogenic Bacteria
Gabriel M. F. Almeida et al.
MBIO (2019)
Mucin glycans attenuate the virulence of Pseudomonas aeruginosa in infection
Kelsey M. Wheeler et al.
NATURE MICROBIOLOGY (2019)
Measuring recovery in health-related quality of life during and after pulmonary exacerbations in patients with cystic fibrosis
Patrick A. Flume et al.
JOURNAL OF CYSTIC FIBROSIS (2019)
Animal Models in the Pathophysiology of Cystic Fibrosis
Anna Semaniakou et al.
FRONTIERS IN PHARMACOLOGY (2019)
Changing Prevalence of Lower Airway Infections in Young Children with Cystic Fibrosis
Oded Breuer et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2019)
Pseudomonas aeruginosa defends against phages through type IV pilus glycosylation
Hanjeong Harvey et al.
NATURE MICROBIOLOGY (2018)
DISARM is a widespread bacterial defence system with broad anti-phage activities
Gal Ofir et al.
NATURE MICROBIOLOGY (2018)
The biology of mucus: Composition, synthesis and organization
Rama Bansil et al.
ADVANCED DRUG DELIVERY REVIEWS (2018)
Piperacillin and ceftazidime produce the strongest synergistic phage-antibiotic effect in Pseudomonas aeruginosa
Jumpei Uchiyama et al.
ARCHIVES OF VIROLOGY (2018)
ECFS best practice guidelines: the 2018 revision
Carlo Castellani et al.
JOURNAL OF CYSTIC FIBROSIS (2018)
Bacteriophages are more virulent to bacteria with human cells than they are in bacterial culture; insights from HT-29 cells
Jinyu Shan et al.
SCIENTIFIC REPORTS (2018)
Initial acquisition and succession of the cystic fibrosis lung microbiome is associated with disease progression in infants and preschool children
Marianne S. Muhlebach et al.
PLOS PATHOGENS (2018)
Novel Iron-Chelator DIBI Inhibits Staphylococcus aureus Growth, Suppresses Experimental MRSA Infection in Mice and Enhances the Activities of Diverse Antibiotics in vitro
Maria del Carmen Parquet et al.
FRONTIERS IN MICROBIOLOGY (2018)
Inhibiting Bacterial Drug Efflux Pumps via Phyto-Therapeutics to Combat Threatening Antimicrobial Resistance
Varsha Shriram et al.
FRONTIERS IN MICROBIOLOGY (2018)
Use of a Primary Epithelial Cell Screening Tool to Investigate Phage Therapy in Cystic Fibrosis
Stephanie Trend et al.
FRONTIERS IN PHARMACOLOGY (2018)
Synthetic Immunotherapeutics against Gram-negative Pathogens
Mary Sabulski Feigman et al.
CELL CHEMICAL BIOLOGY (2018)
Phage treatment of an aortic graft infected with & IT;Pseudomonas aeruginosa & IT;
Benjamin K. Chan et al.
EVOLUTION MEDICINE AND PUBLIC HEALTH (2018)
Physicochemical properties of mucus and their impact on transmucosal drug delivery
Jasmim Leal et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2017)
Population Pharmacokinetics of Tobramycin Inhalation Solution in Pediatric Patients With Cystic Fibrosis
Xinting Wang et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2017)
Communication between viruses guides lysis-lysogeny decisions
Zohar Erez et al.
NATURE (2017)
Incident Stenotrophomonas maltophilia infection and lung function decline in cystic fibrosis
Emily E. Barsky et al.
PEDIATRIC PULMONOLOGY (2017)
Phage therapy is highly effective against chronic lung infections with Pseudomonas aeruginosa
Elaine M. Waters et al.
THORAX (2017)
Understanding the Entanglement: Neutrophil Extracellular Traps (NETs) in Cystic Fibrosis
Saira R. Martinez-Aleman et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2017)
Clinical impact of Achromobacter xylosoxidans colonization/infection in patients with cystic fibrosis
M. C. Firmida et al.
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2016)
Multi-level regulation of cellular glycosylation: from genes to transcript to enzyme to structure
Sriram Neelamegham et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2016)
Continuous alternating inhaled antibiotic therapy in CF: A single center retrospective analysis
C. Van de Kerkhove et al.
JOURNAL OF CYSTIC FIBROSIS (2016)
Antimicrobial resistance, respiratory tract infections and role of biofilms in lung infections in cystic fibrosis patients
Oana Ciofu et al.
ADVANCED DRUG DELIVERY REVIEWS (2015)
Coral Mucus Is a Hot Spot for Viral Infections
Hanh Nguyen-Kim et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2015)
Exploring the interactions between bacteriophage-encoded glycan binding proteins and carbohydrates
David J. Simpson et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2015)
Subdiffusive motion of bacteriophage in mucosal surfaces increases the frequency of bacterial encounters
Jeremy J. Barr et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Burkholderia cepacia Complex Phage-Antibiotic Synergy (PAS): Antibiotics Stimulate Lytic Phage Activity
Fatima Kamal et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2015)
The problems of antibiotic resistance in cystic fibrosis and solutions
Carla Lopez-Causape et al.
EXPERT REVIEW OF RESPIRATORY MEDICINE (2015)
Lung Phenotype of Juvenile and Adult Cystic Fibrosis Transmembrane Conductance Regulator-Knockout Ferrets
Xingshen Sun et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2014)
Antimicrobial resistance in the respiratory microbiota of people with cystic fibrosis
Laura J. Sherrard et al.
LANCET (2014)
Characterization of Defects in Ion Transport and Tissue Development in Cystic Fibrosis Transmembrane Conductance Regulator (CFTR)-Knockout Rats
Katherine L. Tuggle et al.
PLOS ONE (2014)
Temperature dependent bacteriophages of a tropical bacterial pathogen
Jinyu Shan et al.
FRONTIERS IN MICROBIOLOGY (2014)
Current concepts: host-pathogen interactions in cystic fibrosis airways disease
Anthony C. Tang et al.
EUROPEAN RESPIRATORY REVIEW (2014)
Bacteriophages and Biofilms
David R. Harper et al.
ANTIBIOTICS-BASEL (2014)
A peptide-morpholino oligomer conjugate targeting Staphylococcus aureus gyrA mRNA improves healing in an infected mouse cutaneous wound model
Andrew J. Sawyer et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2013)
Gene-Silencing Antisense Oligomers Inhibit Acinetobacter Growth In Vitro and In Vivo
Bruce L. Geller et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Re-evolution of the 2-Phenylquinolines: Ligand-Based Design, Synthesis, and Biological Evaluation of a Potent New Class of Staphylococcus aureus NorA Efflux Pump Inhibitors to Combat Antimicrobial Resistance
Stefano Sabatini et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Risk Factors for Bronchiectasis in Children with Cystic Fibrosis
Peter D. Sly et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
A quorum-sensing inhibitor blocks Pseudomonas aeruginosa virulence and biofilm formation
Colleen T. O'Loughlin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Bacteriophage adhering to mucus provide a non-host-derived immunity
Jeremy J. Barr et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Treatment of pulmonary exacerbations in cystic fibrosis
Jayesh M. Bhatt
EUROPEAN RESPIRATORY REVIEW (2013)
PmrB Mutations Promote Polymyxin Resistance of Pseudomonas aeruginosa Isolated from Colistin-Treated Cystic Fibrosis Patients
Samuel M. Moskowitz et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Efficacy of Bacteriophage Therapy in Experimental Sepsis and Meningitis Caused by a Clone O25b:H4-ST131 Escherichia coli Strain Producing CTX-M-15
Flavie Pouillot et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Stenotrophomonas maltophilia Infections in a General Hospital: Patient Characteristics, Antimicrobial Susceptibility, and Treatment Outcome
George Samonis et al.
PLOS ONE (2012)
A Periciliary Brush Promotes the Lung Health by Separating the Mucus Layer from Airway Epithelia
Brian Button et al.
SCIENCE (2012)
Oral T4-like phage cocktail application to healthy adult volunteers from Bangladesh
Shafiqul Alam Sarker et al.
VIROLOGY (2012)
The air-liquid interface and use of primary cell cultures are important to recapitulate the transcriptional profile of in vivo airway epithelia
Alejandro A. Pezzulo et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2011)
Infection, Inflammation, and Lung Function Decline in Infants with Cystic Fibrosis
Naveen Pillarisetti et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Quorum Sensing Inhibitors Increase the Susceptibility of Bacterial Biofilms to Antibiotics In Vitro and In Vivo
Gilles Brackman et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Does bacterial density in cystic fibrosis sputum increase prior to pulmonary exacerbation?
Franziska A. Stressmann et al.
JOURNAL OF CYSTIC FIBROSIS (2011)
Economic burden ofPseudomonas aeruginosainfection in patients with cystic fibrosis
Sujit S. Sansgiry et al.
JOURNAL OF MEDICAL ECONOMICS (2011)
Evaluation of lytic activity of staphylococcal bacteriophage Sb-1 against freshly isolated clinical pathogens
Leila Kvachadze et al.
MICROBIAL BIOTECHNOLOGY (2011)
Effect of oxygen limitation on the in vitro activity of levofloxacin and other antibiotics administered by the aerosol route against Pseudomonas aeruginosa from cystic fibrosis patients
Paula King et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2010)
The Cystic Fibrosis Transmembrane Conductance Regulator Impedes Proteolytic Stimulation of the Epithelial Na+ Channel
Martina Gentzsch et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Bacteriophage Therapy of Salmonella enterica: A Fresh Appraisal of Bacteriophage Therapy
Rosanna Capparelli et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Bacteriophages Can Treat and Prevent Pseudomonas aeruginosa Lung Infections
Laurent Debarbieux et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Resurgence of Colistin: A Review of Resistance, Toxicity, Pharmacodynamics, and Dosing
Lauren M. Lim et al.
PHARMACOTHERAPY (2010)
Cystic Fibrosis Pigs Develop Lung Disease and Exhibit Defective Bacterial Eradication at Birth
David A. Stoltz et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
Human primary bronchial lung cell constructs: The new respiratory models
Kelly BeruBe et al.
TOXICOLOGY (2010)
Tobramycin and FDA-Approved Iron Chelators Eliminate Pseudomonas aeruginosa Biofilms on Cystic Fibrosis Cells
Sophie Moreau-Marquis et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2009)
Importance of DNase and alginate lyase for enhancing free and liposome encapsulated aminoglycoside activity against Pseudomonas aeruginosa
Misagh Alipour et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
Cationic Amphiphiles Increase Activity of Aminoglycoside Antibiotic Tobramycin in the Presence of Airway Polyelectrolytes
Kirstin R. Purdy Drew et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2009)
Metagenomic Analysis of Respiratory Tract DNA Viral Communities in Cystic Fibrosis and Non-Cystic Fibrosis Individuals
Dana Willner et al.
PLOS ONE (2009)
What's new in cystic fibrosis? From treating symptoms to correction of the basic defect
Marijke Proesmans et al.
EUROPEAN JOURNAL OF PEDIATRICS (2008)
Human host defense peptide LL-37 prevents bacterial biofilm formation
Joerg Overhage et al.
INFECTION AND IMMUNITY (2008)
Spread of colistin resistant non-mucoid Pseudomonas aeruginosa among chronically infected Danish cystic fibrosis patients
Helle Krogh Johansen et al.
JOURNAL OF CYSTIC FIBROSIS (2008)
Phage therapy experience at the Eliava Institute
M. Kutateladze et al.
MEDECINE ET MALADIES INFECTIEUSES (2008)
A physical linkage between cystic fibrosis airway surface dehydration and Pseudomonas aeruginosa biofilms
Hirotoshi Matsui et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Glycosylation in cellular mechanisms of health and disease
Kazuaki Ohtsubo et al.
CELL (2006)
Adult cystic fibrosis exacerbations and new strains of Pseudomonas aeruginosa
SD Aaron et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2004)
The interaction of phage and biofilms
IW Sutherland et al.
FEMS MICROBIOLOGY LETTERS (2004)
Macromolecular interactions and ion transport in cystic fibrosis
WB Guggino et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2004)
Evaluation of a cocktail of three bacteriophages for biocontrol of Escherichia coli O157:H7
G O'Flynn et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2004)
Increased airway epithelial Na+ absorption produces cystic fibrosis-like lung disease in mice
M Mall et al.
NATURE MEDICINE (2004)
In vitro pharmacodynamic properties of colistin and colistin methanesulfonate against Pseudomonas aeruginosa isolates from patients with cystic fibrosis
J Li et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Methicillin resistant Staphylococcus aureus (MRSA) infection in cystic fibrosis
LS Miall et al.
ARCHIVES OF DISEASE IN CHILDHOOD (2001)
Share Paper
